Vanguard Fiduciary Trust
INDV icon

Vanguard Fiduciary Trust’s Indivior Pharmaceuticals INDV Stock Holding History

Vanguard Fiduciary Trust’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4M Buy
863,668
+5,492
+0.6% +$199K 0.01% 1051
2026
Q1 		$26.2M Buy
+858,176
New +$28.3M 0.01% 1155

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust's INDV Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Indivior Pharmaceuticals (INDV) stake by 0.64% in Q2 2026, buying an estimated $199K and bringing the position to 863,668 shares worth $35.4M. The position accounts for 0.01% of the portfolio, ranked #1051.

Vanguard Fiduciary Trust first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Vanguard Fiduciary Trust held 863,668 shares of Indivior Pharmaceuticals worth $35.4M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 5,492 Indivior Pharmaceuticals shares in Q2 2026, an estimated $199K.
  • Indivior Pharmaceuticals made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1051 holding.
  • Vanguard Fiduciary Trust first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.